Tools to study and target the Siglec–sialic acid axis in cancer-Reference-Cited by-同舟云学术

Tools to study and target the Siglec–sialic acid axis in cancer

Published:2020-12-21 Issue:21 Volume:288 Page:6206-6225
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:FEBS J

Author:

Läubli Heinz¹,Kawanishi Kunio²,George Vazhappilly Cijo³,Matar Rachel³,Merheb Maxime³,Sarwar Siddiqui Shoib³^ORCID

Affiliation:

1. Laboratory for Cancer Immunotherapy Department of Biomedicine, and Medical Oncology Department of Internal Medicine University Hospital Basel Switzerland

2. Kidney and Vascular Pathology University of Tsukuba Ibaraki Japan

3. Department of Biotechnology American University of Ras Al Khaimah (AURAK) UAE

Funder

American University

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.15647

Reference163 articles.

1. Glycosylation in cancer: mechanisms and clinical implications

2. Glycans in immune recognition and response

3. Tumor-Associated Carbohydrate Antigens

4. Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ST3GAL1 Promotes Malignant Phenotypes in Intrahepatic Cholangiocarcinoma;Molecular & Cellular Proteomics;2024-09

2. MicroRNA:Siglec crosstalk in cancer progression;Current Opinion in Chemical Biology;2024-08

3. Identification of Siglec-10 as a new dendritic cell checkpoint for cervical cancer immunotherapy;Journal for ImmunoTherapy of Cancer;2024-08

4. The sialic acid–Siglec immune checkpoint: an opportunity to enhance immune responses and therapy effectiveness in melanoma;British Journal of Dermatology;2024-01-10

5. Small lectin ligands as a basis for applications in glycoscience and glycomedicine;Chemical Society Reviews;2024